Paper41007616
In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration.
Kocab AJ and 6 others. Biomedicines, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration. Papers, record 41007616. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007616
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R42 EY029625 | NEI NIH HHS | United States | R42EY029625 | PubMed and NIH |
| 5R42EY029625-23 | NIH HHS | United States | R42EY029625 | PubMed and NIH |
Source NIH RePORTER
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2409504 | Pathologic features of senile macular degeneration. | Ophthalmology | 1985 | https://conductscience.org/library/papers/2409504 | PubMed |
| 2 | 1553220 | Histologic features of the early stages of age-related macular degeneration. A statistical analysis. | Ophthalmology | 1992 | https://conductscience.org/library/papers/1553220 | PubMed |
| 3 | 40490177 | Extracellular GMFB activates the non-canonical FAS-FAF1 pathway to induce lysosomal dysfunction in early diabetic retinopathy. | Int J Biol Macromol | 2025 | https://conductscience.org/library/papers/40490177 | PubMed |
| 4 | 12427055 | The role of apoptosis in age-related macular degeneration. | Arch Ophthalmol | 2002 | https://conductscience.org/library/papers/12427055 | PubMed |
| 5 | 11714783 | Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. | J Immunol | 2001 | https://conductscience.org/library/papers/11714783 | PubMed |
| 6 | 31350409 | A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration. | Nat Commun | 2019 | https://conductscience.org/library/papers/31350409 | PubMed |
| 7 | 27849168 | Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma. | J Immunol | 2016 | https://conductscience.org/library/papers/27849168 | PubMed |
| 8 | 22911474 | Enhanced apoptosis in retinal pigment epithelium under inflammatory stimuli and oxidative stress. | Apoptosis | 2012 | https://conductscience.org/library/papers/22911474 | PubMed |
| 9 | 20505194 | Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration. | Invest Ophthalmol Vis Sci | 2010 | https://conductscience.org/library/papers/20505194 | PubMed |
| 10 | 37865470 | Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. | Lancet | 2023 | https://conductscience.org/library/papers/37865470 | PubMed |
| 11 | 19850829 | Inhibition of retinal detachment-induced apoptosis in photoreceptors by a small peptide inhibitor of the fas receptor. | Invest Ophthalmol Vis Sci | 2010 | https://conductscience.org/library/papers/19850829 | PubMed |
| 12 | 35921555 | Mitophagy initiates retrograde mitochondrial-nuclear signaling to guide retinal pigment cell heterogeneity. | Autophagy | 2023 | https://conductscience.org/library/papers/35921555 | PubMed |
| 13 | 35160044 | Cell Death in AMD: The Rationale for Targeting Fas. | J Clin Med | 2022 | https://conductscience.org/library/papers/35160044 | PubMed |
| 14 | 7530337 | Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. | Nature | 1995 | https://conductscience.org/library/papers/7530337 | PubMed |
| 15 | 7530335 | Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) | Nature | 1995 | https://conductscience.org/library/papers/7530335 | PubMed |
| 16 | 7530336 | Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. | Nature | 1995 | https://conductscience.org/library/papers/7530336 | PubMed |
| 17 | 37696275 | Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. | Lancet | 2023 | https://conductscience.org/library/papers/37696275 | PubMed |
| 18 | 34448806 | Hyperreflective Foci, Optical Coherence Tomography Progression Indicators in Age-Related Macular Degeneration, Include Transdifferentiated Retinal Pigment Epithelium. | Invest Ophthalmol Vis Sci | 2021 | https://conductscience.org/library/papers/34448806 | PubMed |
| 19 | 18769672 | Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice. | PLoS One | 2008 | https://conductscience.org/library/papers/18769672 | PubMed |
| 20 | 32560057 | EMT and EndMT: Emerging Roles in Age-Related Macular Degeneration. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32560057 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41516080 | Integrative Landscape of Dry AMD Pathogenesis, Models, and Emerging Therapeutic Strategies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516080 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41007616
GET https://conductscience.org/api/papers/v1/41007616/references?page=2